期刊文献+

腹膜假粘液瘤的临床病理特征及预后 被引量:8

Analysis of the clinical pathologic characteristic and prognosis with pseudomyxoma peritonei.
暂未订购
导出
摘要 目的 :探讨腹膜假粘液瘤 (pseudomyxomaperitonei,PP)的临床病理特征及预后。方法 :回顾性分析我院 1972年 12月至 1999年 12月间收治的 12例PP的临床及随访资料。采用Kaplan Meier法计算患者的生存率。结果 :患者诊断时的平均年龄为 4 9岁 ,原发病灶为阑尾和卵巢的粘液性肿瘤 ,肠梗阻及多次术后切口和全身感染是患者死亡的主要原因。本组患者的中位生存期为 72个月 ,5年生存率为 6 1% ,10年生存率为 19%。结论 :PP可来源于卵巢和阑尾的粘液性肿瘤 ,病理形态虽为良性或低度恶性 ,但患者 10年生存率低。目前尚无根治PP的方法 ,手术是治疗PP唯一肯定的有效方法 。 Objective:To investigate the clinical pathologic characteristic and prognosis with pseudomyxoma peritonei(PP).Methods:The clinical records and follow up data of 12 cases with PP were retrospectivelyanalyzed.Survival rate was calculated using kaplan Meier method.Results: The mean age of the 12 patients at the time of diagnosis was 49 years.PP derived from mucinous tumors of ovary or appendix umors.The major causes of death were intestinal obstruction and infection of incisional wound and total bodycaused by multiple operation.The median survival time was 72 months.5 year survival rate was 61%,and 10 year survival rate was 19%. Conclusions:The PP can derive from ovarian and appendiceal mucinous tumors.The 10 year survival rate was low although it is benign or low potential malignant on pathomorphology.At present,there is no ideal method to treat it.The mainstay of treatment for PP remains cytoreductive surgery.The appendix should be resected routinely.
出处 《现代妇产科进展》 CSCD 2002年第4期268-270,共3页 Progress in Obstetrics and Gynecology
关键词 腹膜假粘液瘤 临床病理学 治疗 预后 PP Pseudomyxoma peritonei Pathology,clinical Treatment outcome Prognosis
  • 相关文献

参考文献9

  • 1[1]Wertheim I,Fleischhacker D,Mclachlin CM,et al.Pseudomyxoma Peritonei:a review of 23 cases[J].Obstet Gynecol,1994,84:17-21
  • 2[2]Ronnett BM,Shmookler BM,Diener-West M,et al.Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women[J]..Int J Gynecol Pathol,1997,16(1):1-9
  • 3[3]Szych C,Staebler A,Connolly DC,et al.Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudimyxoma peritonei in women[J].Am J Pathol,1999,154(6):1848-1855
  • 4[4]Fox H.Pseudomyxoma peritonei[J].Br J Obstet and Gynaecol,1996,103(3):197-198
  • 5[5]Guerrieri C,Franlund B,Fristedt S,et al.Mucinous tumors of the vermiform appendix and ovary,and pseudomyxoma peritonei:histogenetic implications of cytokeratin 7 expression[J].Hum Pathol,1997,28(9):1039-1045
  • 6[6]Hinson FL,Ambrose NS.Pseudomyxoma peritonei[J].Br J Surg,1998,85(10):1332-1339
  • 7[7]Sugarbaker PH.Pseudomyxoma peritonei[J].Cancer Treat Res,1996,81:105-119
  • 8[8]Shyr YM,Su CH,Wang HC,et al.Pseudomyxoma peritonei:does a true mucolytic agent exist? In vitro and in vivo studies[J].Am Surg,1995,61(3):265-270
  • 9[9]Sugarbaker PH,Fernandez-Trigo V,Shamsa F.Cliniclal determinants of treatment failure in patients with Pseudomyxoma peritonei[J].Cancer Treat Res,1996,81:121-132

同被引文献68

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部